Stocksigma LogoStocksigma Logo

Emcure Pharmaceuticals Approves Board Changes and Leadership Re-Appointments at AGM

At its 45th AGM on 21st Sep'26, Emcure Pharmaceuticals' shareholders approved key board leadership changes

Emcure Pharmaceuticals Approves Board Changes and Leadership Re-Appointments at AGM

Emcure Pharmaceuticals Ltd 路 Others (Uncategorized) 路 23 Sept 2026, 11:58 pm

Emcure Pharmaceuticals Approves Board Changes and Leadership Re-Appointments at AGM At its 45th AGM on 21st Sep'26, Emcure Pharmaceuticals' shareholders approved key board leadership changes. Chairman and Non-Executive Non-Independent Director Berjis Desai retired effective 21st Sep'26. MD & CEO Satish Mehta secured a five-year re-appointment commencing 1st Apr'27, while Whole-time Director Dr. Mukund Gurjar was re-appointed for one year effective 28th Aug'26. Additionally, Raghu Kumar was appointed as an Independent Director for a three-year term effective 6th Aug'26.

Original exchange filing (PDF)

More announcements from Emcure Pharmaceuticals Ltd

All Emcure Pharmaceuticals Ltd announcements